Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peri-operative magnesium infusion to prevent postoperative atrial fibrillation after cardiac surgery
NL-OMON54180Recruiting
- Sponsor
- HagaZiekenhuis
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of magnesium sulfate in Atrial fibrillation (AFib) and arrhythmia (2 arms), sponsored by HagaZiekenhuis. Primary endpoint: Incidence of postoperative atrial fibrillation. Started Aug 2022; status: recruiting.
02
Drugs
magnesium sulfate
03
Conditions
Atrial fibrillation (AFib)arrhythmia
Beyond the preview
Go deeper on NL-OMON54180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54180.